New Key Statistics Module, Z-Score and F-Score
OTCPK:LABFF Key Ratios
| Market Cap $ M | 3,261.53 |
| Enterprise Value $ M | 3,304.34 |
| P/E(ttm) | 21.78 |
| PE Ratio without NRI | 21.72 |
| Forward PE Ratio | 29.08 |
| Price/Book | 4.26 |
| Price/Sales | 3.87 |
| Price/Free Cash Flow | 25.18 |
| Price/Owner Earnings | 25.43 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 863.00 |
| EPS (TTM) $ | 3.01 |
| Beneish M-Score | -2.4 |
| 10-y EBITDA Growth Rate % | 28.40 |
| 5-y EBITDA Growth Rate % | 14.60 |
| y-y EBITDA Growth Rate % | -33.40 |
| EV-to-EBIT | 16.53 |
| EV-to-EBITDA | 14.03 |
| PEG | 1.49 |
| Shares Outstanding M | 51.14 |
| Net Margin (%) | 17.79 |
| Operating Margin % | 23.58 |
| Pre-tax Margin (%) | 23.30 |
| Quick Ratio | 1.80 |
| Current Ratio | 3.66 |
| ROA % (ttm) | 14.69 |
| ROE % (ttm) | 21.17 |
| ROIC % (ttm) | 18.53 |
| Dividend Yield % | -- |
| Altman Z-Score | 10.01 |
LABFF Number of Guru Trades
LABFF Volume of Guru Trades
Gurus Latest Trades with OTCPK:LABFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:LABFF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Laboratorios Farmaceuticos Rovi SA Insider Transactions
No Available Data
News about OTCPK:LABFF
Total 0- 1